Multicenter Prospective Trial of Efficacy of Naldemedine for Opioid-Induced Constipation in Patients with Advanced Pancreatic Cancer
Not Applicable
- Conditions
- Opioid-induced constipation
- Registration Number
- JPRN-UMIN000030218
- Lead Sponsor
- Kitasato University School of Medicine Department of Gastroenterology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. presence or suspicion of gastrointestinal stricture 2. difficult ingestion 3. allergy of naldemedine 4. severe mental illness 5. unsuitable case
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of spontaneous bowel movement responders during the 2-week treatment period.
- Secondary Outcome Measures
Name Time Method